Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-02

Clinical Trial Update: Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of oxycodone and pregabalin for oncological (cancer-related) neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Associazione Progetto Oncologia UMAN.A | Conditions: Cancer, Pain | Phase 2 | Status: COMPLETED